[HTML][HTML] Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic …
CQ Huang, Y Min, SY Wang, XJ Yang, Y Liu, B **ong… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …
Surgical treatment of metastatic colorectal cancer
J Chakedis, CR Schmidt - Surgical Oncology Clinics, 2018 - surgonc.theclinics.com
Metastatic disease occurs in half of people with colorectal cancer (CRC). Metastasis spread
through hematogenous or lymphangitic routes and may occur in lymph nodes, liver, lung …
through hematogenous or lymphangitic routes and may occur in lymph nodes, liver, lung …
Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
Background Up to 15 per cent of colorectal cancers present with peritoneal metastases
(CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS+ HIPEC) …
(CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS+ HIPEC) …
Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer
C Yurttas, G Hoffmann, A Tolios, SP Haen… - Journal of Clinical …, 2018 - mdpi.com
Background: Cytoreductive surgery (CRS), followed by hyperthermic intraperitoneal
chemotherapy (HIPEC), combines radical surgery with abdominal heated chemotherapy …
chemotherapy (HIPEC), combines radical surgery with abdominal heated chemotherapy …
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a
viable option for selected patients with peritoneal metastases (PM) from colorectal origin …
viable option for selected patients with peritoneal metastases (PM) from colorectal origin …
Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal …
Aim Peritoneal metastases from colorectal cancer confer the worst survival among all
metastatic sites. The adoption of cytoreductive surgery (CRS) with hyperthermic …
metastatic sites. The adoption of cytoreductive surgery (CRS) with hyperthermic …
[HTML][HTML] Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review—past, present and future
Peritoneal carcinomatosis (PC) has historically been considered a terminal condition with
merely palliative treatment achieving a survival rate measured in months. Cytoreductive …
merely palliative treatment achieving a survival rate measured in months. Cytoreductive …
Adjuvant systemic chemotherapy vs active surveillance following up-front resection of isolated synchronous colorectal peritoneal metastases
KP Rovers, C Bakkers, FN Van Erning… - JAMA …, 2020 - jamanetwork.com
Importance To date, there are no data on the value of adjuvant systemic chemotherapy
following up-front resection of isolated synchronous colorectal peritoneal metastases …
following up-front resection of isolated synchronous colorectal peritoneal metastases …
[HTML][HTML] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection
J Esquivel - Journal of gastrointestinal oncology, 2016 - ncbi.nlm.nih.gov
Background Chemotherapy hyperthermic intraperitoneal chemotherapy (HIPEC) is playing
an ever increasing role in the management of colorectal cancer (CRC) with peritoneal …
an ever increasing role in the management of colorectal cancer (CRC) with peritoneal …
Perioperative systemic therapy for resectable colorectal peritoneal metastases: sufficient evidence for its widespread use? A critical systematic review
KP Rovers, GA Simkens, CJ Punt, S van Dieren… - Critical Reviews in …, 2017 - Elsevier
Abstract Background/Purpose Despite its widespread use, no randomised studies have
investigated the value of perioperative systemic therapy as adjunct to cytoreduction and …
investigated the value of perioperative systemic therapy as adjunct to cytoreduction and …